MedTrace Logo

A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria

NCT00203736 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2006-11-16

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of sulfadoxine-pyrimethamine plus artesunate with that of sulfadoxine-pyrimethamine on its own for the treatment of uncomplicated malaria.

Conditions

Interventions

DRUG

Sulfadoxine-pyrimethamine

DRUG

Artesunate plus sulfadoxine-pyrimethamine

Sponsors & Collaborators

Principal Investigators

  • Karen Barnes, MBChB · University of Cape Town

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Completion
2003-10-31

Countries

  • Mozambique

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00203736 on ClinicalTrials.gov